Repligen | RGEN - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Agilent USD 444M 45M 2026-06
Align Technology USD 193.04M 1.72M 2026-09
Bio Techne USD 55.82M 39.18M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Bruker USD 83.5M 13.9M 2026-09
Charles River Laboratories USD 202.64M 82.75M 2026-09
Danaher USD 1.25B 118M 2026-09
Dentsply International USD 38M 46M 2026-09
General Electric Aerospace USD 2.22B 338M 2026-09
Henry Schein USD 193M 7M 2026-09
Illumina USD 305M 45M 2026-09
IQVIA Holdings USD 608M 1.99B 2026-09
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Pfizer USD 662M 5M 2026-09
Repligen USD 24.31M 3.18M 2026-09
Revvity USD 124.63M 1.51M 2026-09
Standard Biotools USD -7.83M 1.59M 2026-06
Thermo Fisher Scientific USD 2.46B 277M 2026-09
Waters USD -86M 234M 2026-06
West Pharmaceutical Services USD -199.7M 378.8M 2026-09